Physician profile
Thomas E Brown
NPI 1144323049
$5,334.14
in general payments reported to CMS, 2019-2025
18 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $960 · 2022: $1,242 · 2023: $816 · 2024: $1,230 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.02 |
| Education | $172.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $688.72 | 2021-2025 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $613.21 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $583.59 | 2021-2025 | |
| Genzyme Corporation | $561.35 | 2021-2025 | |
| Incyte Corporation | $547.80 | 2022-2025 | Opzelura, Opzelura |
| Abbvie INC. | $501.82 | 2021-2025 | |
| Lilly USA, LLC | $497.15 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $397.35 | 2021-2025 | Tremfya |
| Pfizer INC. | $307.19 | 2021-2025 | |
| Dermavant Sciences, INC. | $162.56 | 2023 | Vtama |
| Ucb, INC. | $132.49 | 2021-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $100.85 | 2024-2025 | Nemluvio |
| Vyne Pharmaceuticals INC. | $83.00 | 2021 | |
| Amgen INC. | $64.21 | 2022-2023 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $51.90 | 2024-2025 | Sotyktu |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.18 | 2025 | Veozah |
| Arcutis Biotherapeutics, INC. | $15.12 | 2023 | |
| Organon LLC | $8.65 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.